Philips Respironics Trilogy Evo Universal Ventilator Recall Affects 113,717 Units Worldwide in 2026
Philips Respironics recalled 113,717 Trilogy Evo Universal ventilators worldwide on March 2, 2026. The recall cites a condition where using non-pneumatic nebulizers may cause a discrepancy between the set tidal volume and the delivered tidal volume. Patients and caregivers should stop using the device immediately and contact Philips Respironics or their healthcare provider for instructions.
Quick Facts at a Glance
Recall Date
March 2, 2026
Hazard Level
HIGH
AI Risk Assessment
CRITICAL
Brand
Philips Respironics
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, ELDERLY
Hazard Information
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips Respironics, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The Trilogy Evo Universal is a home-use ventilator platform used to manage patients with respiratory failure. It relies on nebulized medication delivery, typically through nebulizers, as part of the treatment plan.
Why This Is Dangerous
Using non-pneumatic nebulizers with Trilogy Evo may cause a mismatch between the intended tidal volume and the actual tidal volume delivered to the patient, potentially impairing ventilation.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
The recall centers on a life-sustaining device. Stop-use instructions must be followed to prevent potential respiratory compromise while awaiting further guidance.
Practical Guidance
How to identify if yours is affected
Verify device is Trilogy Evo Universal.
Check software version 1.05.15.00.
Confirm use of non-pneumatic nebulizers with the device.
Where to find product info
FDA recall page and Philips Respironics recall notices.
What timeline to expect
Remedy or replacement timelines will be provided by Philips; typical recall processes may take weeks.
If the manufacturer is unresponsive
Document all attempts to contact Philips and your healthcare provider.
Contact FDA or local health authority if you cannot obtain guidance.
Consider legal counsel if a delay results in harm.
How to prevent similar issues
Do not use non-pneumatic nebulizers with Trilogy Evo until cleared by a clinician.
Monitor for signs of inadequate ventilation such as increased work of breathing or hypoxia.
Keep the recall notice and serial/identification information for your records.
Documentation advice
Keep recall letters, communications with Philips, dates of inquiries, and any symptom reports; document device serial numbers and software version.
Product Details
Model numbers: All Model No., All UDI, All Serial No.
Where sold: Worldwide distribution; US nationwide; numerous countries listed
When sold: Not specified
Price: Not specified
Philips Respironics recalled 113,717 Trilogy Evo ventilators worldwide on March 2, 2026. The recall concerns software Version 1.05.15.00 and the use of non-pneumatic nebulizers with the Trilogy Evo platform. Hospitals and patients should stop using the device immediately and follow recall instructions from Philips Respironics or their healthcare provider.
Philips Respironics recalled 113,717 Trilogy Evo O2 home-use ventilators worldwide on March 2, 2026 after determining that using non-pneumatic nebulizers with the device can cause a mismatch between the set tidal volume and the delivered tidal volume. The defect could lead to under- or over-ventilation with serious health consequences. Stop using the device immediately and follow the recall steps.
Philips Respironics recalls 113,717 Trilogy Evo O2 home-use ventilators in 2026. The Obstruction Alarm may fail to trigger within required standards, delaying warning for airway obstruction for up to four breaths. Stop using the device and follow recall instructions from Philips or your clinician.
Philips Respironics recalled 113,717 Trilogy Evo home-use ventilators worldwide after finding the Obstruction Alarm may fail to trigger, potentially delaying alerts by up to four breaths. The devices were distributed nationwide in the United States and internationally. Consumers should stop using the device immediately and follow the manufacturer’s recall instructions.
Philips Respironics recalled 113,717 Trilogy Evo Universal home-use ventilators sold by multiple retailers after alarms may fail to trigger. The obstruction alarm may not trigger within the required timeframe, delaying warning by up to four breaths. Patients should stop using the device and follow the manufacturer’s recall instructions or contact their healthcare provider for guidance.
Philips Respironics recalled 113,717 Trilogy EV300 ventilators sold worldwide through healthcare distributors on March 2, 2026. Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may cause a mismatch between the set tidal volume and the delivered tidal volume. Patients and healthcare providers should stop using the device immediately and follow the recall instructions from the 제조
Philips Respironics recalled 113,717 Trilogy EV300 ventilators sold in the United States and internationally after determining the Obstruction Alarm may fail to trigger within required standards. The alarm can delay alerting caregivers for up to four breaths. Patients and healthcare providers should stop using the device immediately and follow recall instructions from Philips or their clinician.